In the article “Acute Paralytic Post-Bariatric Surgery Axonal Polyneuropathy: Clinical Features and Outcome” [Eur Neurol. 2019;81:239–45. DOI: 10.1159/000503286] by AlShareef et al., a line in the abstract (“The percent of patients who were able to ambulate independently at 6 months were 16% with IVIg versus 66.7% without IVIg”) should read: “The percent of patients who were able to ambulate independently at 6 months were 33.3% with IVIg versus 66.7% without IVIg.” Also, a sentence in the Results section [“The use of IVIg was not associated with increased chance to walk independently (16% with IVIg vs. 66.7% without IVIg, p = 0.242)”] should read: “The use of IVIg was not associated with increased chance to walk independently at 6 months (33.3% with IVIg vs. 66.7% without IVIg, p = 0.567).” Also, in Table 3, the percentage who received intravenous immunoglobulin in the “walk independently at 6 months” group should read 33.3% instead of 16.67%, with a p value of 0.567 instead of 0.242. Furthermore, the female (n) in the “walk with assistance at 6 months” group should read 4 instead of 6. Finally, the percentage of patients who received IVIg in the whole cohort in Table 1 should read 46.2% instead of 41.67%.
The corrected section of Table 3 is shown here:
© 2021 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2021
